MT2010-08R Influenza Vaccine Specific Immune Responses After Allogeneic Hematopoietic Cell Transplantation: Are One or Two Vaccine Doses Needed?
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Immune Response to Vaccine
The primary endpoint of this study is to measure the response to the vaccine with laboratory studies including viral specific B and T cell immune responses (baseline compared to Week 8).
8 Weeks After Vaccination
Michael Verneris, M.D.
Masonic Cancer Center, University of Minnesota
United States: Institutional Review Board
|Masonic Cancer Center, University of Minnesota||Minneapolis, Minnesota 55455|